Publication Name	World Journal of Gastrointestinal Pathophysiology
Manuscript ID	17521
Country	Ireland

Received	2015-03-11 09:45
Peer-Review Started	2015-03-12 08:46
To Make the First Decision	2015-04-13 14:52
Return for Revision	2015-04-15 18:56
Revised	2015-04-23 02:10
Second Decision	2015-06-12 07:47
Accepted by Journal Editor-in-Chief	2015-06-12 20:42
Accepted by Company Editor-in-Chief	2015-07-14 10:04
Articles in Press	2015-07-14 10:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-07-23 12:33
Publish the Manuscript Online	2015-08-17 16:11

ISSN	2150-5330 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Microbiology
Manuscript Type	Review
Article Title	Designer probiotics: Development and applications in gastrointestinal health
Manuscript Source	Invited Manuscript
All Author List	Roy D Sleator
Funding Agency and Grant Number
Corresponding Author	Roy D Sleator, Senior Lecturer and PI, Department of Biological Sciences, Cork Institute of Technology, Bishopstown, Cork, Ireland. roy.sleator@cit.ie
Key Words	Gastrointestinal tract; Probiotics; BetL; Listeria monocytogenes; Bifidobacterium; Lactobacillus
Core Tip	Genetically engineered probiotic bacteria, with improved in vivo stress survival and persistence, have the potential to enhance, and in some instances replace, conventional prophylactic and therapeutic measures. This is particularly relevant in the developing world, where chronic and acute infections, and their associated sequelae impose a significant clinical and economic burden.
Publish Date	2015-08-17 16:11
Citation	Sleator RD. Designer probiotics: Development and applications in gastrointestinal health. World J Gastrointest Pathophysiol 2015; 6(3): 73-78
URL	http://www.wjgnet.com/2150-5330/full/v6/i3/73.htm
DOI	http://dx.doi.org/10.4291/wjgp.v6.i3.73

Full Article (PDF)	WJGP-6-73.pdf
Full Article (Word)	WJGP-6-73.doc
Manuscript File	17521-Review.doc
Answering Reviewers	17521-Answering reviewers.pdf
Audio Core Tip	17521-Audio core tip.wav
Conflict-of-Interest Disclosure Form	17521-Conflict-of-interest statement.pdf
Copyright License Agreement	17521-Copyright assignment.pdf
Peer-review Report	17521-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	17521-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	17521-Scientific misconduct check.pdf
Scientific Editor Work List	17521-Scientific editor work list.pdf